Literature DB >> 6331481

Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.

A De Blasi, M Cortellaro, C Costantini.   

Abstract

Multiple (100 mg twice daily for 21 days) but not single (100 mg) oral doses of metoprolol significantly reduced the number (Bmax) and the KD of beta-adrenoceptors on intact lymphocytes from nine healthy volunteers. Sulphinpyrazone (400 mg twice daily for 21 days) did not change lymphocyte beta-adrenoceptors and did not modify their reaction to chronic metoprolol. In vitro sulphinpyrazone (10-4M) increased [3H]-DHA specific binding on intact lymphocytes. This effect was not modified by metoprolol, sulphinpyrazone or the two combined. Metoprolol and sulphinpyrazone did not interact in the experimental model of beta-adrenoceptors on intact lymphocytes in conditions mimicking long-term treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331481      PMCID: PMC1463574          DOI: 10.1111/j.1365-2125.1984.tb05020.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

Review 1.  Drug therapy: metoprolol.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1979-09-27       Impact factor: 91.245

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Does sulphinpyrazone prevent recurrence of myocardial infarction?

Authors: 
Journal:  Lancet       Date:  1982-03-27       Impact factor: 79.321

Review 4.  beta-Adrenoceptor antagonists: new drugs and new indications.

Authors:  J Koch-Weser; W H Frishman
Journal:  N Engl J Med       Date:  1981-08-27       Impact factor: 91.245

5.  Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes.

Authors:  J F Krall; M Connelly; M L Tuck
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

6.  Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.

Authors:  R D Aarons; A S Nies; J Gal; L R Hegstrand; P B Molinoff
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Beta-adrenoceptors of human lymphocytes: decrease in affinity of agonist for (-)3h-dihydroalprenolol binding sites by cytoplasmic fractions.

Authors:  Y Watanabe; R T Lai; H Higuchi; H Maeda; H Yoshida
Journal:  Life Sci       Date:  1981-03-23       Impact factor: 5.037

8.  Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects.

Authors:  R E Goldstein; L C Corash; J F Tallman; C R Lake; J Hyde; C C Smith; N L Capurro; J C Anderson
Journal:  Am J Cardiol       Date:  1981-05       Impact factor: 2.778

Review 9.  Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.

Authors:  E H Margulies; A M White; S Sherry
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

10.  Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol.

Authors:  J Fraser; J Nadeau; D Robertson; A J Wood
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

View more
  1 in total

1.  Sulphinpyrazone increases lymphocyte beta-adrenoceptors in man.

Authors:  A De Blasi; S Cotecchia
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.